Upper airway edema in 43 patients with hereditary angioedema

Ying Yang Xu, Yu Xiang Zhi, Rui Ling Liu, Timothy Craig, Hong Yu Zhang

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background Upper airway edema (UAE) occurs infrequently in hereditary angioedema (HAE), but still results in significant morbidity and mortality. Objective To assess patients with HAE and UAE to determine whether unique features exist that can predict the risk of UAE. Methods Clinical, laboratory, and genetic data were compared between 43 patients with HAE and 743 UAE attacks and those without UAE and normal controls after ethics committee approval. Results Most patients had their first episode of UAE in the second (25.6%), third (27.9%), and fourth (23.3%) decades of life, and the mean age at onset was 27.3 years. Evolution of UAE from initial to maximum symptoms was 4.6 hours on average, and most cases (69.8%) progressed within 4 hours. Dyspnea was the most frequent manifestation in per-episode (92.2%) and per-patient (97.7%) analyses. Men developed more asphyxiation attacks (19 vs 2) and underwent more tracheotomies (12 vs 2) than did women. UAE was associated with facial edema in half the studied patients. Patients with a positive family history of UAE had a high risk of UAE attacks. Conclusion Symptoms limited to the upper airway should be taken seriously. Dyspnea may be the only manifestation of UAE. UAE attacks most commonly start spontaneously and usually progress rapidly, as quickly as 30 minutes, from awareness of symptoms to maximum airway involvement. Patients with a positive UAE family history are predisposed to UAE attacks, and men appear to be more apt to develop asphyxiation than women.

Original languageEnglish (US)
Pages (from-to)539-544.e1
JournalAnnals of Allergy, Asthma and Immunology
Volume112
Issue number6
DOIs
StatePublished - Jan 1 2014

Fingerprint

Hereditary Angioedemas
Edema
Asphyxia
Dyspnea
Ethics Committees
Tracheotomy

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Cite this

Xu, Ying Yang ; Zhi, Yu Xiang ; Liu, Rui Ling ; Craig, Timothy ; Zhang, Hong Yu. / Upper airway edema in 43 patients with hereditary angioedema. In: Annals of Allergy, Asthma and Immunology. 2014 ; Vol. 112, No. 6. pp. 539-544.e1.
@article{b7fc9dccc71247c383840a5a9514d72a,
title = "Upper airway edema in 43 patients with hereditary angioedema",
abstract = "Background Upper airway edema (UAE) occurs infrequently in hereditary angioedema (HAE), but still results in significant morbidity and mortality. Objective To assess patients with HAE and UAE to determine whether unique features exist that can predict the risk of UAE. Methods Clinical, laboratory, and genetic data were compared between 43 patients with HAE and 743 UAE attacks and those without UAE and normal controls after ethics committee approval. Results Most patients had their first episode of UAE in the second (25.6{\%}), third (27.9{\%}), and fourth (23.3{\%}) decades of life, and the mean age at onset was 27.3 years. Evolution of UAE from initial to maximum symptoms was 4.6 hours on average, and most cases (69.8{\%}) progressed within 4 hours. Dyspnea was the most frequent manifestation in per-episode (92.2{\%}) and per-patient (97.7{\%}) analyses. Men developed more asphyxiation attacks (19 vs 2) and underwent more tracheotomies (12 vs 2) than did women. UAE was associated with facial edema in half the studied patients. Patients with a positive family history of UAE had a high risk of UAE attacks. Conclusion Symptoms limited to the upper airway should be taken seriously. Dyspnea may be the only manifestation of UAE. UAE attacks most commonly start spontaneously and usually progress rapidly, as quickly as 30 minutes, from awareness of symptoms to maximum airway involvement. Patients with a positive UAE family history are predisposed to UAE attacks, and men appear to be more apt to develop asphyxiation than women.",
author = "Xu, {Ying Yang} and Zhi, {Yu Xiang} and Liu, {Rui Ling} and Timothy Craig and Zhang, {Hong Yu}",
year = "2014",
month = "1",
day = "1",
doi = "10.1016/j.anai.2014.03.003",
language = "English (US)",
volume = "112",
pages = "539--544.e1",
journal = "Annals of Allergy, Asthma and Immunology",
issn = "1081-1206",
publisher = "American College of Allergy, Asthma and Immunology",
number = "6",

}

Upper airway edema in 43 patients with hereditary angioedema. / Xu, Ying Yang; Zhi, Yu Xiang; Liu, Rui Ling; Craig, Timothy; Zhang, Hong Yu.

In: Annals of Allergy, Asthma and Immunology, Vol. 112, No. 6, 01.01.2014, p. 539-544.e1.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Upper airway edema in 43 patients with hereditary angioedema

AU - Xu, Ying Yang

AU - Zhi, Yu Xiang

AU - Liu, Rui Ling

AU - Craig, Timothy

AU - Zhang, Hong Yu

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Background Upper airway edema (UAE) occurs infrequently in hereditary angioedema (HAE), but still results in significant morbidity and mortality. Objective To assess patients with HAE and UAE to determine whether unique features exist that can predict the risk of UAE. Methods Clinical, laboratory, and genetic data were compared between 43 patients with HAE and 743 UAE attacks and those without UAE and normal controls after ethics committee approval. Results Most patients had their first episode of UAE in the second (25.6%), third (27.9%), and fourth (23.3%) decades of life, and the mean age at onset was 27.3 years. Evolution of UAE from initial to maximum symptoms was 4.6 hours on average, and most cases (69.8%) progressed within 4 hours. Dyspnea was the most frequent manifestation in per-episode (92.2%) and per-patient (97.7%) analyses. Men developed more asphyxiation attacks (19 vs 2) and underwent more tracheotomies (12 vs 2) than did women. UAE was associated with facial edema in half the studied patients. Patients with a positive family history of UAE had a high risk of UAE attacks. Conclusion Symptoms limited to the upper airway should be taken seriously. Dyspnea may be the only manifestation of UAE. UAE attacks most commonly start spontaneously and usually progress rapidly, as quickly as 30 minutes, from awareness of symptoms to maximum airway involvement. Patients with a positive UAE family history are predisposed to UAE attacks, and men appear to be more apt to develop asphyxiation than women.

AB - Background Upper airway edema (UAE) occurs infrequently in hereditary angioedema (HAE), but still results in significant morbidity and mortality. Objective To assess patients with HAE and UAE to determine whether unique features exist that can predict the risk of UAE. Methods Clinical, laboratory, and genetic data were compared between 43 patients with HAE and 743 UAE attacks and those without UAE and normal controls after ethics committee approval. Results Most patients had their first episode of UAE in the second (25.6%), third (27.9%), and fourth (23.3%) decades of life, and the mean age at onset was 27.3 years. Evolution of UAE from initial to maximum symptoms was 4.6 hours on average, and most cases (69.8%) progressed within 4 hours. Dyspnea was the most frequent manifestation in per-episode (92.2%) and per-patient (97.7%) analyses. Men developed more asphyxiation attacks (19 vs 2) and underwent more tracheotomies (12 vs 2) than did women. UAE was associated with facial edema in half the studied patients. Patients with a positive family history of UAE had a high risk of UAE attacks. Conclusion Symptoms limited to the upper airway should be taken seriously. Dyspnea may be the only manifestation of UAE. UAE attacks most commonly start spontaneously and usually progress rapidly, as quickly as 30 minutes, from awareness of symptoms to maximum airway involvement. Patients with a positive UAE family history are predisposed to UAE attacks, and men appear to be more apt to develop asphyxiation than women.

UR - http://www.scopus.com/inward/record.url?scp=84901450904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901450904&partnerID=8YFLogxK

U2 - 10.1016/j.anai.2014.03.003

DO - 10.1016/j.anai.2014.03.003

M3 - Article

C2 - 24698534

AN - SCOPUS:84901450904

VL - 112

SP - 539-544.e1

JO - Annals of Allergy, Asthma and Immunology

JF - Annals of Allergy, Asthma and Immunology

SN - 1081-1206

IS - 6

ER -